Dawei Biology Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $24.8M

Dawei Biology General Information

Description

Developer of medical instruments and diagnostic reagents. The company develops biomedical testing instruments and diagnostic reagents to better serve the medical field and patient diagnoses.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • B106, Zhongguancun Biomedical Park
  • No. 5 Kaituo Road, Haidian District
  • Beijing
  • China
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • B106, Zhongguancun Biomedical Park
  • No. 5 Kaituo Road, Haidian District
  • Beijing
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dawei Biology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 23-Jun-2022 $24.8M Completed Generating Revenue
2. Early Stage VC 27-Mar-2021 Completed Generating Revenue
1. Early Stage VC 27-Jun-2019 Completed Generating Revenue
To view Dawei Biology’s complete valuation and funding history, request access »

Dawei Biology Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
HollyCon Corporation Minority
SinoKing Capital Corporate Venture Capital Minority
To view Dawei Biology’s complete investors history, request access »

Dawei Biology FAQs

  • When was Dawei Biology founded?

    Dawei Biology was founded in 2017.

  • Where is Dawei Biology headquartered?

    Dawei Biology is headquartered in Beijing, China.

  • What industry is Dawei Biology in?

    Dawei Biology’s primary industry is Biotechnology.

  • Is Dawei Biology a private or public company?

    Dawei Biology is a Private company.

  • What is the current valuation of Dawei Biology?

    The current valuation of Dawei Biology is .

  • What is Dawei Biology’s current revenue?

    The current revenue for Dawei Biology is .

  • Who are Dawei Biology’s investors?

    HollyCon and SinoKing Capital have invested in Dawei Biology.

  • When was Dawei Biology acquired?

    Dawei Biology was acquired on 23-Jun-2022.

  • Who acquired Dawei Biology?

    Dawei Biology was acquired by Sichuan Maccura Biotechnology Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process